This product is housed in a separate website which can be located at ucaps.in. Please click at this site to get a very comprehensive treatment of our research offerings.

Our user is typically an independent board member, corporate planners, CXOs and knowledge managers who need independent, credible, analytical and evidence rich research.

We all know that, when consuming research for effective decision making, organizations consider quality and affordability as two most important factors. The need to use research is gaining traction primarily for:

• understanding how systemic issues are dealt with
• tracking competitor activities
• adopting leading practices especially related to technology and processes
• becoming a part of appropriate affinity groups to share knowledge and build a positive image

We offer for use by key decision makers, our intensively researched monthly publications on topics of great relevance.

• Healthcare
• Banking & Financial Services
• Consumer industry
• Industrials
• Economic

The value proposition of our monthly offering is terrific:

• It is India specific research meant largely for Indian clients
• Most reports are one off; issued when it is of topical interest
• Our reports are sharply focused, issued monthly on topics that clients wish to read about
• Our reports are affordable and compliment/substitute their internal existing team effort
• Our publications are analytical and data rich

Our pricing is competitive:

• Rs 500,000 per annum + GST@18%  to receive 12 monthly reports related to each domain
• In addition, complimentary copies of 1 or 2 important special studies conducted during the year (which are otherwise priced at Rs.150,000 per study)

We respect our competition. They are of impeccable repute, have an international flavour, experienced besides being cerebral. In our own small way, we believe we are no less. Having been part of such organisations and consumed such research in the past, we believe, they do not always satisfy the explosive appetite of discerning knowledge that can be consumed immediately.

We have made a beginning with Indian pharmaceutical players who are on the cusp of global leadership in many areas and they need well researched data to take quick informed decisions. Other segments are at a stage of development and expect to reach all segments by 2025.